Remote Clinical Solutions Inc is categorized under Electromedical Equipment in San Francisco, CA and active since 2002.
Remote Clinical Solutions Inc was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Electromedical Equipment business, which does work in the B2B market, and is classified as a Electromedical Equipment, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Rebecca Eaton at the company’s single location by writing to 3319 Divisadero St, San Francisco, California CA 94123 or by phoning (507) 332-2204. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Remote Clinical Solutions Inc |
| Contact Person: | Rebecca Eaton |
| Address: | 3319 Divisadero St, San Francisco, California 94123 |
| Phone Number: | (507) 332-2204 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Electromedical Equipment |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Remote Clinical Solutions Inc was started in 2002 to provide professional Electromedical Equipment under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Rebecca Eaton for inquiries that concern Remote Clinical Solutions Inc by calling the company number (507) 332-2204, as your correspondence is most welcome. Additionally, the physical location of the single location of Remote Clinical Solutions Inc can be found at the coordinates as well as the street address 3319 Divisadero St in San Francisco, California 94123.
For its online presence, you may visit Remote Clinical Solutions Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.